Ramadeus Capsules Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 17-06-2024
- Paid Up Capital ₹ 7.50 M
as on 17-06-2024
- Company Age 4 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 Cr
as on 17-06-2024
- Revenue %
(FY 2022)
- Ebitda
- Net Worth
- Total Assets 170.97%
(FY 2022)
About Ramadeus Capsules
The Corporate was formerly known as Ramadeus Softgel Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹3.50 Cr.
Sham Aneja, Smita Jhanwar, Kanika Chadha, and One other member serve as directors at the Company.
- CIN/LLPIN
U24303HP2020PTC007805
- Company No.
007805
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Feb 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Baddi, Himachal Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ramadeus Capsules?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sham Aneja | Director | 13-Mar-2024 | Current |
Smita Jhanwar  | Director | 22-Feb-2022 | Current |
| Kanika Chadha | Additional Director | Current | |
| Dipty Manchanda | Director | 22-Feb-2022 | Current |
Financial Performance and Corporate Structure Insights of Ramadeus Capsules.
Ramadeus Capsules Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ramadeus Capsules?
In 2021, Ramadeus Capsules had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indicaps Healthcare Private LimitedActive 3 years 6 monthsSmita Jhanwar and Dipty Manchanda are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 18 Jun 2022 | ₹3.50 Cr | Open |
How Many Employees Work at Ramadeus Capsules?
Ramadeus Capsules has a workforce of 0 employees as of Mar 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ramadeus Capsules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ramadeus Capsules's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
